<DOC>
	<DOCNO>NCT00219167</DOCNO>
	<brief_summary>After wash-out ( 1 2 week ) , 2 4 week single-blind placebo run-in period , eligible patient randomize receive lisinopril 10 mg , aliskiren 75 mg , 150 mg 300 mg period 8 week</brief_summary>
	<brief_title>A Clinical Study Assess Efficacy Safety Aliskiren Elderly With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Inclusion Criteria Patients least 65 yearsold Patients essential hypertension Exclusion Criteria Severe hypertension History evidence secondary form hypertension History Hypertensive encephalopathy cerebrovascular accident . Other protocoldefined inclusion exclusion criterion also apply .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>hypertension</keyword>
	<keyword>aliskiren</keyword>
	<keyword>age</keyword>
</DOC>